MAXONA is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.
MAXONA Pharmaceuticals, Inc. has raised $6.9M in total funding. The most recent round was Series B. The last funding was announced in December 2022.
MAXONA Pharmaceuticals, Inc.'s investors include Inspira Financial.
MAXONA Pharmaceuticals, Inc. is headquartered in Malvern, United States.
MAXONA is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.
MAXONA Pharmaceuticals, Inc. is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MAXONA Pharmaceuticals, Inc. — Funding & Investors." VCBacked, December 15, 2022, https://www.vcbacked.co/company/maxona-pharmaceuticals-inc. Accessed October 2, 2026.
VCBacked. (2022). MAXONA Pharmaceuticals, Inc. — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/maxona-pharmaceuticals-inc
{{cite web |title=MAXONA Pharmaceuticals, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/maxona-pharmaceuticals-inc |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated